Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related ENDP
3 JPMorgan Bull Calls Hitting The Market
Benzinga's M&A Chatter for Monday March 16, 2015
CoLucid Pharmaceuticals on deck for IPO (Seeking Alpha)
Related FHN
Benzinga's Top Upgrades
FBR Capital Upgrades First Horizon National To Market Perform
Food Retail Group Is On Sale - Cramer's Lightning Round (4/23/15) (Seeking Alpha)

Analysts at Cantor Fitzgerald downgraded Endo Health Solutions (NASDAQ: ENDP) from “hold” to “sell.” The target price for Endo Health Solutions is set to $30. Endo Health's shares closed at $35.96 yesterday.

Analysts at Morgan Stanley downgraded First Horizon National (NYSE: FHN) from “overweight” to “neutral.” The target price for First Horizon National is set to $11. First Horizon National's shares closed at $11.25 yesterday.

Analysts at Piper Jaffray downgraded Vera Bradley (NASDAQ: VRA) from “overweight” to “neutral.” The price target for Vera Bradley has been lowered from $32 to $24. Vera Bradley's shares closed at $22.46 yesterday.

Berenberg downgraded Oracle (NASDAQ: ORCL) from “buy” to “sell.” The target price for Oracle has been lowered from $35 to $28. Oracle's shares closed at $34.12 yesterday.

Latest Ratings for ENDP

DateFirmActionFromTo
Apr 2015Deutsche BankMaintainsBuy
Apr 2015JP MorganReinstatesOverweight
Mar 2015Morgan StanleyReinstatesOverweight

View More Analyst Ratings for ENDP
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ENDP + FHN)

Around the Web, We're Loving...